AndreaBozzo/ceres-open-data-index huggingface dataset:
2015 CMHS Uniform Reporting System (URS) Table for Colorado

2015 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Colorado. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
2015 CMHS Uniform Reporting System (URS) Table for Missouri

2015 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Missouri. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Patent AT-E401558-T1: [Translated] CALIBRATION OF AN OPTICAL FMCW BACKSCATTER MEASUREMENT SYSTEM

The object of the invention is to provide a method of calibrating an optical FMCW backscattering measurement system that improves the precision of the measurement. The problem is solved by a method comprising the steps of A. Converting said received sensor signal to a complex received electrical signal as a function of said modulation frequency fm, said complex received electrical signal being represented by a magnitude part and a phase angle part as a function of said modulation frequency fm; B. Performing a transformation of said received electrical signal to provide a backscattering signal as a function of location between said first and second ends of said sensor and beyond said second end; C. From said backscattering signal as a function of location determining characteristics of a curve representative of said backscattering signal beyond said second end; D. Correcting said magnitude part of said received electrical signal and said phase angle part of said received electrical signal in a predetermined dependence of said curve; and E. Repeating step B) on the basis of the corrected received electrical signal.
Patent AT-E400666-T1: [Translated] USE OF A TYPE III RESTRICTION ENZYME FOR ISOLATION OF SEQUENCE TAGS COMPRISING MORE THAN 25 NUCLEOTIDES

The type III restriction enzyme EcoP15I is used to isolate from cDNA of an expressed gene a tag comprising more than 25 nucleotides and capable of identifying the expressed gene, wherein the 3' end of the tag is defined by a cleavage site of the type III restriction enzyme and the 5' end of the tag is defined by the cleavage site of another restriction enzyme that is closest to the 3' end of the cDNA of the expressed gene. The tag of the invention allows accurate quantitative gene expression analysis and rapid gene expression profiling in any organism for which no expressed sequence tag (EST) database is available.
New functions for Cox-2 in health and disease: Report of "The		  Third International Workshop on Cox-2", Ka'upulehu, Kona, Hawaii,		  USA, 30 August to 2 September 1999

New functions for Cox-2 in health and disease: Report of "The		  Third International Workshop on Cox-2", Ka'upulehu, Kona, Hawaii,		  USA, 30 August to 2 September 1999
Instructions for State Courts on Applying for State Court Improvement Program (CIP) Funds for Fiscal Year (FY) 2025

This Program Instruction (PI) provides guidance on the eligibility requirements and grant application procedures for the State CIP grant for FY 2025, including updating the five-year strategic plan, and to provide guidance on the requirements for state courts to continuously assess and improve the handling of court proceedings related to child welfare and enhance collaboration with title IV-B/IV-E agencies and tribes.

Metadata-only record linking to the original dataset. Open original dataset below.
Detection ofMycobacterium avium subspecies paratuberculosisspecific IS900 insertion sequences in bulk-tank milk samples obtained from different regions throughout Switzerland

SinceMycobacterium aviumsubspeciesparatuberculosis(MAP) was isolated from intestinal tissue of a human patient suffering Crohn's disease, a controversial discussion exists whether MAP have a role in the etiology of Crohn's disease or not. Raw milk may be a potential vehicle for the transmission of MAP to human population. In a previous paper, we have demonstrated that MAP are found in raw milk samples obtained from a defined region in Switzerland. The aim of this work is to collect data about the prevalence of MAP specificIS900insertion sequence in bulk-tank milk samples in different regions of Switzerland. Furthermore, we examined eventual correlation between the presence of MAP and the somatic cell counts, the total colony counts and the presence ofEnterobacteriaceae.
Th2 cytokines and asthma — Interleukin-9 as a therapeutic target for asthma

Asthma is a complex heritable inflammatory disorder of the airways in which the development of clinical disease depends on environmental exposure. It has been well established that T helper type 2 (TH2) lymphocytes and their cytokines have an important role in allergic asthma. Interleukin (IL)-9, a member of the TH2 cytokine family, has recently been implicated as an essential factor in determining mucosal immunity and susceptibility to atopic asthma. In this review we examine the critical experiments and observations that support this hypothesis. We also discuss these results in comparison with the experiments supporting the involvement of other TH2 cytokines such as IL-4, IL-5 and IL-13.
ORMDL proteins are a conserved new family of endoplasmic reticulum membrane proteins

Background
          Annotations of completely sequenced genomes reveal that nearly half of the genes identified are of unknown function, and that some belong to uncharacterized gene families. To help resolve such issues, information can be obtained from the comparative analysis of homologous genes in model organisms.
        
        
          Results
          While characterizing genes from the retinitis pigmentosa locus RP26 at 2q31-q33, we have identified a new gene, ORMDL1, that belongs to a novel gene family comprising three genes in humans (ORMDL1, ORMDL2 and ORMDL3), and homologs in yeast, microsporidia, plants, Drosophila, urochordates and vertebrates. The human genes are expressed ubiquitously in adult and fetal tissues. The Drosophila ORMDL homolog is also expressed throughout embryonic and larval stages, particularly in ectodermally derived tissues. The ORMDL genes encode transmembrane proteins anchored in the endoplasmic reticulum (ER). Double knockout of the two Saccharomyces cerevisiae homologs leads to decreased growth rate and greater sensitivity to tunicamycin and dithiothreitol. Yeast mutants can be rescued by human ORMDL homologs.
        
        
          Conclusions
          From protein sequence comparisons we have defined a novel gene family, not previously recognized because of the absence of a characterized functional signature. The sequence conservation of this family from yeast to vertebrates, the maintenance of duplicate copies in different lineages, the ubiquitous pattern of expression in human and Drosophila, the partial functional redundancy of the yeast homologs and phenotypic rescue by the human homologs, strongly support functional conservation. Subcellular localization and the response of yeast mutants to specific agents point to the involvement of ORMDL in protein folding in the ER.
Patent AT-E399605-T1: [Translated] DEVICE FOR CLEANING PAINT BUCKETS

The invention relates to the automated cleaning of paint buckets (2).In a device intended for this purpose the curled mouth rims (6) of the buckets are pushed slidingly one by one into the teeth (22,23) of a lifting fork (21), tilted and positioned in upside down position at the location of a scraping station (12), where paint residues are removed from the inner surface by scraping. A thus cleaned bucket is then transported in upside down position to a flushing station (17) where the last paint residues are removed by flushing and spraying clean. The thus cleaned buckets are finally tilted back to their upright position and stacked onto each other in nested form.
A note on clinical presentations of amebic liver abscess: an overview from 62 Thai patients

Background
          Amebic liver abscess is a tropical disease with a wide spectrum of clinical presentations. Given the often nonspecific nature of the complaints related to amebic abscess, a retrospective review of patients with confirmed disease to recognize the most common patterns of presentation is useful. Here, we study the clinical presentations of 62 Thai patients with amebic liver abscess. We also compare the clinical presentations of Anti HIV seronegative and Anti HIV seropositive patients.
        
        
          Methods
          A retrospective case review was carried out for 62 Thai patients who had been diagnosed with amebic liver abscess. Clinical information was collected, including symptoms and signs, location and number of abscesses. The Anti HIV serology laboratory investigation was also reviewed.
        
        
          Results
          According to our study, the common clinical symptoms and signs are abdominal pain (85.5 %), fever and chills (74.2 %), and abdominal tenderness (69.4 %). The location of the abscess was predominantly in the right lobe (74.2 %), and most of patients had a single abscess (77.4 %). Similar trends in clinical presentations were observed in both Anti HIV seropositive and Anti HIV seronegative subjects.
        
        
          Conclusions
          In conclusion, the clinical presentations of our amebic liver abscess patients were similar to those in previous reports. A similarity to those in the pyogenic liver abscess patients can be observed. Nevertheless, we could not detect important significant differences in the clinical presentations between Anti HIV seropositive and Anti HIV seronegative groups of patients.
Mycobacterial and nonbacterial pulmonary complications in hospitalized patients with human immunodeficiency virus infection: A prospective, cohort study

Background
          A prospective observational study was done to describe nonbacterial pulmonary complications in hospitalized patients with human immunodeficiency virus (HIV) infection.
        
        
          Methods
          The study included 1,225 consecutive hospital admissions of 599 HIV-infected patients treated from April 1995 through March 1998. Data included demographics, risk factors for HIV infection, Acute Physiology and Chronic Health Evaluation (APACHE) II score, pulmonary complications, CD4+ lymphocyte count, hospital stay and case-fatality rate.
        
        
          Results
          Patient age (mean ± SD) was 38.2 ± 8.9 years, 62% were men, and 84% were African American. The median APACHE II score was 14, and median CD4+ lymphocyte count was 60/μL. Pulmonary complications were Pneumocystis carinii pneumonia (85) in 78 patients, Mycobacterium avium complex (51) in 38, Mycobacterium tuberculosis (40) in 35, Mycobacterium gordonae (11) in 11, Mycobacterium kansasii (10) in 9, Cytomegalovirus (10) in 10, Nocardia asteroides (3) in 3, fungus ball (2) in 2, respiratory syncytial virus (1), herpes simplex virus (1), Histoplasma capsulatum (1), lymphoma (3) in 3, bronchogenic carcinoma (2) in 2, and Kaposi sarcoma (1). The case-fatality rate of patients was 11% with Pneumocystis carinii pneumonia; 5%, Mycobacterium tuberculosis; 6%, Mycobacterium avium complex; and 7%, noninfectious pulmonary complications.
        
        
          Conclusion
          Most pulmonary complications in hospitalized patients with HIV are from Pneumocystis and mycobacterial infection.
Patent AT-E401173-T1: [Translated] HAIR CUTTER

In a hair cutting device in which a head portion (1) is connected such that the head portion can laterally tilt and vertically move, the head portion is stably supported in a front-rear direction, and the number of parts is reduced. In a hair cutting device, the head portion for cutting hair is connected to an upper portion of a main body grip portion (2) such that the head portion can laterally tilt and vertically move, the head portion is resiliently biased upward. An upper end of the main body grip portion is formed with an opened space (26) into which an accommodating body (10c) having a motor (8) of a lower portion of the head portion is inserted. Front and back surfaces of the accommodating body have a pair of left and right shaft portions (70) which are connected to an inner surface (78) of an opened space of the main body grip portion such that the shaft portions can turn andverticallymove and come into contact with slide contact, and a contact portion (75) which is provided lower than the pair of shaft portions and which comes into slide contact with an inner surface of the opened space.
Compound 527034: Benzamide, N-(1,1-dimethylethyl)-N-methyl-

Chemical compound data from PubChem database. IUPAC Name: N-tert-butyl-N-methylbenzamide. Molecular Formula: C12H17NO. Molecular Weight: 191.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application

Background
          A model-based analysis of oligonucleotide expression arrays we developed previously uses a probe-sensitivity index to capture the response characteristic of a specific probe pair and calculates model-based expression indexes (MBEI). MBEI has standard error attached to it as a measure of accuracy. Here we investigate the stability of the probe-sensitivity index across different tissue types, the reproducibility of results in replicate experiments, and the use of MBEI in perfect match (PM)-only arrays.
        
        
          Results
          Probe-sensitivity indexes are stable across tissue types. The target gene's presence in many arrays of an array set allows the probe-sensitivity index to be estimated accurately. We extended the model to obtain expression values for PM-only arrays, and found that the 20-probe PM-only model is comparable to the 10-probe PM/MM difference model, in terms of the expression correlations with the original 20-probe PM/MM difference model. MBEI method is able to extend the reliable detection limit of expression to a lower mRNA concentration. The standard errors of MBEI can be used to construct confidence intervals of fold changes, and the lower confidence bound of fold change is a better ranking statistic for filtering genes. We can assign reliability indexes for genes in a specific cluster of interest in hierarchical clustering by resampling clustering trees. A software dChip implementing many of these analysis methods is made available.
        
        
          Conclusions
          The model-based approach reduces the variability of low expression estimates, and provides a natural method of calculating expression values for PM-only arrays. The standard errors attached to expression values can be used to assess the reliability of downstream analysis.
Compound 525200: Chloromethyl 3-chlorohexanoate

Chemical compound data from PubChem database. IUPAC Name: chloromethyl 3-chlorohexanoate. Molecular Formula: C7H12Cl2O2. Molecular Weight: 199.07. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Mental Health (MH) and Substance Use Disorder (SUD) Provider Directory - Site List

<STRONG>A. SUMMARY</STRONG>
This dataset contains information of Mental Health (MH) and Substance Use Disorder (SUD) programs / sites. It serves as provider directory for the general public to know and search for MH and SUD programs / sites contracted with the City and County of San Francisco. 

<STRONG>B. HOW THE DATASET IS CREATED</STRONG>
The dataset is pulled from our electronic systems. 

<STRONG>C. UPDATE PROCESS</STRONG>
The dataset is updated nightly through sf.gov through Application Programming Interface (API) whenever there are changes. There is monthly review and tracking. 

<STRONG>D. HOW TO USE THIS DATASET</STRONG>
There are filters for some data fields for quick search. For example, if we want to search all MH and SUD programs that serve women, we would use the Gender filter and select “Women” and “All”.

<STRONG>E. RELATED DATASETS</STRONG>
Compound 525047: N-(3-chloro-4-methylphenyl)hexanamide

Chemical compound data from PubChem database. IUPAC Name: N-(3-chloro-4-methylphenyl)hexanamide. Molecular Formula: C13H18ClNO. Molecular Weight: 239.74. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Hospital Cost Report Audited Data Print Image: 2018

This print image version of the Institutional Cost Report (ICR) has been audited by the DOH. is the Institutional Cost Report (ICR) is a uniform report completed by New York hospitals to report income, expenses, assets, liabilities, and statistics to the Department of Health (DOH). Under DOH regulations, (Part 86-1.2), Article 28 hospitals are required to file financial and statistical data with DOH annually. The data filed is part of the ICR and is received electronically through a secured network. This data is used to develop Medicaid rates, assist in the formulation of reimbursement methodologies, and analyze trends. For more information, check out: http://www.health.ny.gov/facilities/hospital/
2008-2010 NSDUH State-Specific Substate Region Estimates and Maps

This report provides State-specific tables and maps showing substate region prevalence estimates for 25 measures of substance use and mental disorders based on the 2008 to 2010 National Survey on Drug Use and Health (NSDUH).  Results include past year alcohol use disorder and illicit drug use disorder among persons aged 12 or older by 362 substate regions within the 50 States and the District of Columbia. Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE).
Pervasive properties of the genomic signature

Background
          The dinucleotide relative abundance profile can be regarded as a genomic signature because, despite diversity between species, it varies little between 50 kilobase or longer windows on a given genome. Both the causes and the functional significance of this phenomenon could be illuminated by determining if it persists on smaller scales. The profile is computed from the base step "odds ratios" that compare dinucleotide frequencies to those expected under the assumption of stochastic equilibrium (thorough shuffling). Analysis is carried out on 22 sequences, representing 19 species and comprised of about 53 million bases all together, to assess stability of the signature in windows ranging in size from 50 kilobases down to 125 bases.
        
        
          Results
          Dinucleotide relative abundance distance from the global signature is computed locally for all non-overlapping windows on each sequence. These distances are log-normally distributed with nearly constant variance and with means that tend to zero slower than reciprocal square root of window size. The mean distance within genomes is larger for protist, plant, and human chromosomes, and smaller for archaea, bacteria, and yeast, for any window size.
        
        
          Conclusions
          The imprint of the global signature is locally pervasive on all scales considered in the sequences (either genomes or chromosomes) that were scanned.
Compound 529399: 4-Ethyl-2-methyl-1,3-dioxolane

Chemical compound data from PubChem database. IUPAC Name: 4-ethyl-2-methyl-1,3-dioxolane. Molecular Formula: C6H12O2. Molecular Weight: 116.16. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525764: Pentyloxypropyloxydimethylsilane

Chemical compound data from PubChem database. IUPAC Name: dimethyl-pentoxy-propoxysilane. Molecular Formula: C10H24O2Si. Molecular Weight: 204.38. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526245: 1,2,4,9-Tetrabromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,2,4,9-tetrabromodibenzofuran. Molecular Formula: C12H4Br4O. Molecular Weight: 483.77. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Hospital Inpatient Discharges (SPARCS De-Identified): 2024

The Statewide Planning and Research Cooperative System (SPARCS) Inpatient De-identified File contains discharge level detail on patient characteristics, diagnoses, treatments, services, and charges.

This data file contains basic record level detail for the discharge. The de-identified data file does not contain data that is protected health information (PHI) under Health Insurance Portability and Accountability Act (HIPAA). The health information is not individually identifiable; all data elements considered identifiable have been redacted. For example, the direct identifiers regarding a date have the day and month portion of the date removed.

For more information visit: <a href=https://www.health.ny.gov/statistics/sparcs/>https://www.health.ny.gov/statistics/sparcs/</a>
Complications and Unplanned Hospital Visits - PPS-Exempt Cancer Hospital - National

Prospective Payment System (PPS)-Exempt Cancer Hospital Quality Reporting (PCHQR) Complications and Unplanned Hospital Visits. This dataset evaluates the percentage of patients who are receiving PCH-based outpatient chemotherapy treatment for all cancer types except leukemia who were admitted to the hospital or visited the emergency department for one of 10 conditions within 30 days after treatment.
Managed Care Individual Provider Network Data: June 30, 2012

The primary purpose for the Provider Network Data System is to collect data needed to evaluate the provider networks including physicians, hospitals, labs, home health agencies, durable medical equipment providers, etc., for all types of Managed Care plans in New York State, including HIV Special Need Plans (SNP), Family Health Plus (FHP) Buy-In, Programs of All-Inclusive Care for the Elderly (PACE), and Non-PACE Managed Long-Term Care (MLTC) plans.

This dataset reflects individual provider data.

Provider Network Data System information is self-reported.

For more information, check out http://www.health.ny.gov/health_care/managed_care/.
ChemIDplus

ChemIDplus, the Chemical Identification Plus Database, is no longer updated. These are the final files from February 22, 2023. All ChemIDplus data have been incorporated into PubChem.

ChemIDplus was a dictionary of over 400,000 chemicals (names, synonyms, and structures). ChemIDplus includes links to NLM and other databases and resources, including links to federal, state and international agencies.  NLM makes a subset of ChemIDplus data available for download. The ChemIDplus Subset does not include the structure or the toxicity data available from the NLM web versions of the database. The ChemIDplus Subset is updated monthly.